PEAK EXPIRATORY FLOW RATE WITH SALBUTAMOL PLUS IPRATROPIUM BROMIDE VERSUS SALBUTAMOL ALONE IN ACUTE ASTHMA IN CHILDREN IN LAHORE, PAKISTAN: A RANDOMIZED CONTROLLED TRIAL
Abstract
Background: Paediatric asthma usually presents with acute exacerbation and requires hospital admission and emergency management. The objective of this study was to compare the peak expiratory flow rate (PEFR) with salbutamol plus ipratropium bromide versus salbutamol alone in acute asthma in children in Lahore, Pakistan.
Material & Methods: This randomized controlled trial was undertaken at The Children’s Hospital and The Institute of Child Health, Lahore, Pakistan from 14-04-2017 to 17-10-2017. One hundred children with acute asthma with age 2-12 years were enrolled. Fifty patients each were randomly assigned to experimental and control groups by lottery method. At presentation, PEFR was measured by using a peak flow meter. Experimental group received three doses of 2.5 mg salbutamol and 500 mcg of ipratropium at 20 minutes intervals. Control group received three doses of 2.5 mg salbutamol alone. PEFR was again measured after 60 minutes.
Results: Mean age in experimental group was 9.60±2.86 years, whereas it was 8.68±3.28 years in control group, almost similar. Mean weight in experimental group was 29.50±8.26 kg, whereas it was 28.24±10.07 kg in control group, almost similar. Baseline mean PEFR% was 43.18±4.25 in experimental, while it was 42.48±4.82 in control group. Mean PEFR% at 60 minutes after intervention was 82.88±7.54 in experimental, while it was 60.04±6.05 in control group. PEFR% was higher in experimental group showing its better effect than the control group (p<.00001).
Conclusion: The peak expiratory flow rate was higher with salbutamol plus ipratropium bromide versus salbutamol alone in acute asthma in children in Lahore, Pakistan.
Keywords
Full Text:
PDFReferences
Lee MO, Sivasankar S, Pokrajac N, Smith C, Lumba-Brown A. Emergency department treatment of asthma in children: A review. J Am Coll Emerg Physicians Open 2020;1(6):1552-15. https://doi.org/10.1002/emp2.12224
Alhasoon MA, Alharbi AN, Almohamadi WS, et al. Reasons for recurrent visits of emergency department by pediatric asthmatic patients in Al-Qassim Region. J Family Med Prim Care 2020;9(4):2099-2103. https://doi.org/10.4103/jfmpc.jfmpc_966_19
Liang TZ, Chao JH. Inhaled Corticosteroids [updated 2022 May 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. https://pubmed.ncbi.nlm.nih.gov/29261858/
Hsu E, Bajaj T. Beta 2 Agonists. [updated 2022 Jun 23]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing 2022. https://www.ncbi.nlm.nih.gov/books/NBK542249/
Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol 2011;128(6):1165-74. https://doi.org/10.1016/j.jaci.2011.10.024
Al-Shamrani A, Al-Harbi AS, Bagais K, Alenazi A, Alqwaiee M. Management of asthma exacerbation in the emergency departments [published correction appears in Int J Pediatr Adolesc Med 2020;7(4):212]. Int J Pediatr Adolesc Med 2019;6(2):61-6. https://doi.org/10.1016/j.ijpam.2019.02.001
Ortiz-Alvarez O, Mikrogianakis A, Committee AC. Managing the paediatric patient with an acute asthma exacerbation. Paediatr Child Health 2012;17(5):251. https://doi.org/10.1093/pch/17.5.251
Williams DM, Rubin BK. Clinical pharmacology of bronchodilator medications. Respir Care 2018;63(6):641-54. https://doi.org/10.4187/respcare.06051
Desai C. Meyler's side effects of drugs: The international encyclopedia of adverse drug reactions and interactions. Indian J Pharmacol 2016;48(2):224. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825447/
Chakraborti A, Lodha R, Pandey R, Kabra S. Randomized controlled trial of ipratropium bromide and salbutamol versus salbutamol alone in children with acute exacerbation of asthma. Indian J Pediatr 2006;73(11):979-83. https://doi.org/10.1007/BF02758300
Hossain A, Barua U, Roy G, Sutradhar S, Rahman I, Rahman G. Comparison of salbutamol and ipratropium bromide versus salbutamol alone in the treatment of acute severe asthma. Mymensingh Med J 2013;22(2):345-52. https://pubmed.ncbi.nlm.nih.gov/23715360/
Watanasomsiri A, Phipatanakul W. Comparison of nebulized ipratropium bromide with salbutamol vs salbutamol alone in acute asthma exacerbation in children [randomized controlled trial]. Ann Allergy Asthma Immunol 2006;96(5):701-6. https://doi.org/10.1016/S1081-1206(10)61068-X
Memon BN, Parkash A, Khan KMA, Gowa MA, Bai C. Response to nebulized salbutamol versus combination with ipratropium bromide in children with acute severe asthma. J Pak Med Assoc 2016;66(3):243-6. https://pubmed.ncbi.nlm.nih.gov/26968269/
Kohistani TA. Acute severe asthma; salbutamol plus ipratropium bromide nebulization versus salbutamol nebulization alone. Professional Med J 2007;14:586-90. https://doi.org/10.29309/TPMJ/2007.14.04.4810
Rao NA, Rizvi N. The efficacy of Salbutamol delivered by inhaler plus spacer device and nebulizer in acute asthma: A comparative study. J Coll Physicians Surg Pak 2002;12:579-82. http://www.ayubmed.edu.pk/JAMC/PAST/21-1/Fayaz.pdf
Joiya SJ, Khan MA, Haq FU, Ahmad Z. Comparison of outcome of salbutamol alone and salbutamol in combination with ipratropium bromide in acute asthma in children. Professional Med J 2020;27(6):1103-7. https://doi.org/10.29309/TPMJ/2020.27.06.3218
Singh JP, Singh R, Gupta RC, Bharadwaja B. A comparative study of bronchodilator actions of ipratropium bromide (atrovent) & salbutamol (ventolin) on exercise induced bronchial asthma. J Assoc Physicians India 1992 Aug;40(8):545-7. https://pubmed.ncbi.nlm.nih.gov/1308496/
Sharma A, Madaan A. Nebulized salbutamol vs salbutamol and ipratropium combination in asthma. Indian J Pediatr 2004;71(2):121-4. https://doi.org/10.1007/BF02723090
Qureshi F, Pestian J, Davis P, Zaritsky A. Effect of nebulized ipratropium on the hospitalization rates of children with asthma. N Engl J Med 1998;339(15):1030-5. https://doi.org/10.1056/NEJM199810083391503
O'Driscoll BR, Taylor RJ, Horsley MG, Chambers DK, Bernstein A. Nebulised salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 1989 Jun 24;1(8652):1418-20. https://doi.org/10.1016/S0140-6736(89)90126-8
DOI: https://doi.org/10.46903/gjms/20.04.1168
Refbacks
- There are currently no refbacks.
Copyright (c) 2022. Muhammad Abdullah Butt, Muhammad Affan Arif Butt, Sonia Saleem, Bin Tul Huda, Muhammad Maaz Arif, Shahid Mahmood Sahi.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
JOURNAL INDEXING